Lv21
110 积分 2025-04-21 加入
Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer
1小时前
已完结
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
13天前
已完结
The PIKK Family of Protein Kinases
17天前
已关闭
The PIKK Family of Protein Kinases
17天前
已关闭
Evolving Landscape of HER2-Targeted Therapies for Gastric Cancer Patients
24天前
已完结
Structures of the HER2–HER3–NRG1β complex reveal a dynamic dimer interface
24天前
已完结
Molecular Pathways and Mechanisms of HER2 in Cancer Therapy
25天前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
25天前
已完结
Disitamab Vedotin: First Approval
27天前
已完结
Disitamab Vedotin: First Approval
1个月前
已完结
皖公网安备34019202002308
